Surface Modification of Medical-Grade Titanium and Polyvinyl Chloride with a Novel Catechol-Terminated Compound Containing Zwitterionic Sulfobetaine Functionality for Antibacterial Application.

Healthcare-associated infection, mainly through medical device-associated infection, remains a critical issue in hospital care. Bacterial adhesion, proliferation, and biofilm formation on the device surface have been considered the foremost cause of medical device-associated infection. Different means have been explored to reduce microbial attachment and proliferation, including forming a bactericidal or microbial adhesion-resistant surface layer. Fear of limited bactericidal capability if the dead microbes remained adhered to the surface has withheld the widespread use of a bactericidal surface in medical devices if it was intended for long-term use. By contrast, constructing a microbial adhesion-resistant or antifouling surface, such as a surface with zwitterionic functionality, would be more feasible for devices intended to be used for the long term. Nevertheless, a sophisticated multi-step chemical reaction process would be needed. Instead, a simple immersion method that utilized a novel mussel-inspired catechol compound with zwitterionic sulfobetaine functionality, ZDS, was explored in this investigation for the surface modification of substrates with distinctively different surface characteristics, including titanium and polyvinyl chloride. Dopamine, NaIO